Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-18-000047
Filing Date
2018-07-26
Accepted
2018-07-26 16:07:13
Documents
1
Period of Report
2018-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_153263561757068.html 4  
1 FORM 4 wf-form4_153263561757068.xml 4 3821
  Complete submission text file 0001615219-18-000047.txt   5168
Mailing Address 585 WEST 500 SOUTH BOUNTIFUL UT 84010
Business Address
RANDLE STUART A (Reporting) CIK: 0001256144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 18971817

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations